Scientists Are On The Verge Of Providing A “Limitless Supply” Of Blood For People Diagnosed With Blood Disorders


Researchers and experts assert they are “tantalizingly close” to providing a “limitless supply” for people diagnosed with blood disorders and immune system condition and those who are in dire need of transfusions.

Experts and scientists have been considering several ways to work on stem cells in a way that turns them into blood artificially four almost two decades.

The newly discovered technique

After repeated, non-ending attempts a group of researchers could compound various types of blood stem cells that developed different types of human blood cells when injected into lab rats.

Postdoctoral researcher Dr Ryohichi Sugimura who works at the Daley Lab in Boston Children’s Hospital in the US, said: “This step opens up an opportunity to take cells from patients with genetic blood disorders, use gene editing to correct their genetic defect and make functional blood cells,” according to leading Journal Nature.

“This also gives us the potential to have a limitless supply of blood stem cells and blood by taking cells from universal donors,” she continued, “This could potentially augment the blood supply for patients who need transfusions.”

Likewise, Professor Shahin Fafii, of Cornell University, who is the head of another team of researchers, succedded in turning adult rat cells into rat blood stem cells.

Furthermore, when some rats have had their immune system less inefficient, their immune system was recovered after they were provided with blood stem cells

Surely, human are capable of receiving similar treatment if they are diagnosed with immunity system conditions or blood disorders.

Potential cancer

However, it is claimed that using stem cells can cause cancer.

Different researchers and teams have worked on the newly discovered technique; however, none discovered any potential traces of cancer being developed after using the stem cells as rats were prone to the experience and they are, unlike humans, short-lived creatures. However, researchers will consider the prospects if they are any side effects or potential cancer that can be caused by the technique.

Dr Caroline Guibentif of Cambridge University wrote in Nature, “When you use mice, they only live up to a year and a half or so. Humans develop cancer partly because they have a long lifespan. We are talking about different timescales.”

“Whatever works in a mouse, this is one of the reasons we need to double check it in a more thorough way.”